Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
MOGENRY
product5 mentionslast seen Nov 5, 2026
Investigational optogenetic gene therapy for inherited retinal dystrophies, based on multi-characteristic opsin technology.
Relationships 16
- Nanoscope TherapeuticsdevelopsMOGENRY99% confidence5 sources
- MOGENRYapplies toretinitis pigmentosa treatment99% confidence5 sources
- MOGENRYdepends onmulti-characteristic opsin99% confidence4 sources
- MOGENRYapplies toStargardt disease treatment99% confidence4 sources
- MOGENRYapplies toinherited retinal dystrophies treatment99% confidence2 sources
- U.S. Food and Drug AdministrationapprovesMOGENRY98% confidence3 sources
- MOGENRYapplies toinherited retinal dystrophies96% confidence1 source
- Pharmaceuticals and Medical Devices AgencyapprovesMOGENRY96% confidence3 sources
- MOGENRYapplies toinherited retinal dystrophy treatment95% confidence1 source
- MOGENRYdepends onmulti-characteristic opsin technology95% confidence1 source
- MOGENRYapplies todry age-related macular degeneration treatment90% confidence1 source
- European Medicines AgencyapprovesMOGENRY85% confidence1 source
- Pharmaceutical and Medical Device AgencyapprovesMOGENRY85% confidence1 source
- MOGENRYapplies togeographic atrophy treatment80% confidence1 source
- Food and Drug AdministrationapprovesMOGENRY75% confidence1 source
- MOGENRYapplies toLeber congenital amaurosis treatment75% confidence1 source
Relationship
MOGENRYapplies toinherited retinal dystrophies treatment
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- newsPR NewswireOct 14, 2026Nanoscope Therapeutics Appoints Gene Therapy Operations Leader Troy Short as Senior Vice President, Manufacturing and Supply Chain
MOGENRY is designed for patients with photoreceptor loss and vision impairment due to retinal degeneration
- newsPR NewswireSep 29, 2026Nanoscope Therapeutics to Present at Meeting on the Mesa 2026
MOGENRY® (sonpiretigene isteparvovec; MCO-010), for the treatment of inherited retinal dystrophies